儿童非传染性尿道炎的复发风险在阿达利穆马布缩水期间:一项国际多中心回顾性研究
Achille Marino1, Maria Vittoria Cicinelli2, Elisabetta Miserocchi2
1ASST Gaetano Pini-CTO, Milan, Italy.
Arthritis & rheumatology (Hoboken, N.J.)
|April 2, 2025
概括
较慢的阿达利穆马布 (ADA) 减缓降低了儿科患者非传染性脑膜炎 (NIU) 复发的风险. 建议在ADA逐渐减少期间逐渐减少剂量和密切监测NIU的管理.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 儿科 儿科 儿科
背景情况:
- 非传染性脑膜炎 (NIU) 是儿童视力丧失的重要原因之一.
- 阿达利穆马布 (ADA) 是用于儿科NIU的有效生物疗法.
- 减少ADA需要仔细考虑,以防止疾病复发.
研究的目的:
- 评估在阿达利穆马布 (ADA) 逐渐减少期间儿科患者NIU复发的风险.
- 为了确定在ADA剂量减少期间NIU复发的预测因素.
主要方法:
- 儿童NIU患者接受ADA逐渐缩小的多中心回顾性队列研究.
- 考克斯比例危险回归分析,以确定NIU复发的风险因素.
主要成果:
- 46%的患者在ADA逐渐减少期间经历了NIU复发.
- 较慢的ADA逐渐缩减时间表与明显较低的复发率 (HR 0.40) 相关.
- 对于青少年异常性关节炎相关性脑膜炎 (JIA-U),在两年不活动后开始逐渐减少ADA,降低了复发风险 (HR 0.65).
结论:
- 阿达利穆马布 (ADA) 的逐渐减缓显著影响儿科患者膜炎复发风险.
- 建议对ADA采取逐步,缓慢逐渐的方法.
- 在ADA逐渐减少期间和之后,密切监测患者至关重要,以管理NIU复发.
相关概念视频
Renal Failure: Dose Adjustments
45
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
45
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109
Pharmacovigilance
755
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
Open Angle Glaucoma: Treatment
368
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
368
Glaucoma: Overview
482
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
482


